Case Report
Use of a Nutritional Therapy, Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI), to Achieve Improvement in Two Different Cases of Colitis
Amir Awad1 and Victoria S. Jasion2*1Westchase Gastroenterology, Tampa, FL, United States
2Entera Health, Inc., Medical Affairs, Cary, NC, United States
- *Corresponding Author:
- Victoria S. Jasion, PhD
Entera Health, Department of Medical Affairs
2000 Regency Parkway, Suite 255
Cary NC 27518, USA
Tel: 785-813-2953
E-mail: victoria.jasion@enterahealth.com
Received date: March 10, 2015; Accepted date: April 4, 2015; Published date: April10, 2015
Citation: Awad A, Jasion VS (2015) Use of a Nutritional Therapy, Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI), to Achieve
Improvement in Two Different Cases of Colitis. J Gastrointest Dig Syst 5:274. doi:10.4172/2161-069X.1000274
Copyright: © 2015 Awad A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited
Abstract
Two independent retrospective cases of refractory colitis, one ischemic and one pan ulcerative -colitis, successfully managed over a year by the inclusion of a non-probiotic, non-antibiotic, medical food therapeutic, serum-derived bovine immunoglobulin/protein isolate (SBI), are presented. In addition to patient-reported outcomes and satisfaction regarding their symptomology, both patients had resolved colitis during routine colonoscopies performed at least one year after they had included SBI into their regimens.
